Suchergebnisse - "Bosch, Bronwyn"

PubPharm (8)

1

Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens

enthalten in: Open forum infectious diseases | 2024

von Sokhela, S. | Venter, W. | Bosch, B. | +23

2

Weight and Metabolic Changes After Switching From Tenofovir Alafenamide/Emtricitabine (FTC)+Dolutegravir (DTG), Tenofovir Disoproxil Fumarate (TDF)/FTC + DTG, and TDF/FTC/Efavirenz to TDF/Lamivudine/DTG

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Bosch, B. | Akpomiemie, G. | Chandiwana, N. | +6

3

Risks of metabolic syndrome in the ADVANCE and NAMSAL trials

enthalten in: Frontiers in reproductive health | 2023

von Tovar Sanchez, T. | Mpoudi-Etame, M. | Kouanfack, C. | +13

4

Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa

enthalten in: Open forum infectious diseases | 2022

von Sokhela, S. | Bosch, B. | Hill, A. | +16

5

Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trials

enthalten in: AIDS (London, England) | 2022

von Venter, F. | Sokhela, S. | Calmy, A. | +17

CommentOn: AIDS. 2022 Nov 1;36(13):1899-1900. - PMID 36172875

6

Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Sokhela, S. | Bosch, B. | Hill, A. | +8

7

Weight gain stopping/switch rules for antiretroviral clinical trials

enthalten in: AIDS (London, England) | 2021

von Venter, W. | Sokhela, S. | Calmy, A. | +18

CommentIn: AIDS. 2022 Jun 1;36(7):1053-1054. - PMID 35652678

8

Participants on Dolutegravir Resuppress Human Immunodeficiency Virus RNA After Virologic Failure : Updated Data from the ADVANCE Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Pepperrell, T. | Venter, W. | McCann, K. | +8

1
[1]